PROMISE Registry: PROspective Study on Management of Ischemic Stroke Secondary to mEvo Registry

Conditions

• Management of Ischemic Stroke
• Medium Vessel Occlusion

Eligibility Criteria

Sex

ALL

Age

18 Years - 85 Years

Healthy Volunteers

Not accepted

Study Details

Investigators are conducting a real world, observational, prospective, multicenter study to better understand treatment for patients with MeVo and distal vessel occlusions in the U.S post publication of recent MeVO trials.

Key Dates

First listed

Aug 5, 2026

Start date

Jul 11, 2026

Status verified

Jul 2026

Primary completion

Jul 11, 2029

Completion

Jul 11, 2030

Study Design

Enrollment

652 participants (estimated)

Arms

• Arm: Endovascular Treatment
  Intra-arterial Treatment
• Arm: Medical Management
  Intravenous Thrombolytic

Primary Outcome Measure

Clinical outcomes based on distribution of modified Rankin Scale score(mRS) [ Time Frame: 3 months +/- 15 days ]

Central Contacts

• Kaustubh Limaye, MD, FAHA
  317-963-7378
  [email protected]

Locations (1)

Find similar trials in Indianapolis, IN